Stock Chart

AMPH

$27.92 +5.40%
Score: 55.0 HOLD
1Y Target $28.45 +1.9%
i
1Y Price Target

This target is derived from long-term trendline analysis and projected growth.

Note: Targets are based on the assumption that the current primary trend continues. They should be used as reference points, not guarantees.

Target may adjust dynamically as the stock trend reverses or accelerates.
LEAPs: SELL $35
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $35
Premium: $0.85
Expiry: Jun 18, 2026
Target: $32
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $27.14 - $29.1 NEUTRAL
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.03
Vol: 1.41x (vs SPY: 1.4x | vs QQQ: 1.6x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About AMPH - Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United …

Key Statistics

Market Cap $1B
P/E Ratio 11.72

This AMPH stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track AMPH's price movements with trendlines, gamma walls, and key support/resistance levels.